HIF1A and type 2 diabetes mellitus: These findings indicate that HIF-1 is undoubtedly involved in diabetic β-cell dysfunction, and an elucidation of the role of HIF-1 in T2DM may be helpful in identifying HIF-1 as a therapeutic target.